Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Singapore Institute Of Advanced Medicine Holdings Median PS Value?
Singapore Institute Of Advanced Medicine HoldingsSGX:9G2 +3.33% Median PS Value is S$0.00 as of Aug. 19, 2026. The stock has 2 warning signs investors should review. Among 261 Healthcare Providers & Services companies, Singapore Institute Of Advanced Medicine Holdings ranks worse than 383141.38% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
SGX:9G2's Price-to-Median-PS-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.72 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Singapore Institute Of Advanced Medicine Holdings's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.031
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singapore Institute Of Advanced Medicine Holdings Median PS Value Related Terms
Singapore Institute Of Advanced Medicine Holdings Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singapore Institute Of Advanced Medicine Holdings Median PS Value Chart
Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend
Jun21
Jun22
Jun23
Jun24
Jun25
Median PS Value
0.00
0.00
0.00
0.00
0.00
Singapore Institute Of Advanced Medicine Holdings Quarterly Data
SGX:9G2 vs HCA, THC, DVA: Median PS Value Comparison
For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singapore Institute Of Advanced Medicine Holdings Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
10-Year Median PS Ratio is 0.
Singapore Institute Of Advanced Medicine Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was S$0.006.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a Median PS Value of S$0.00 as of Aug. 19, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. According to the industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #999999 out of 261 companies in the Healthcare Providers & Services industry.
Is Singapore Institute Of Advanced Medicine Holdings' Median PS Value too high?
Singapore Institute Of Advanced Medicine Holdings' current Median PS Value is S$0.00. Based on the distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #999999 out of 261 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Singapore Institute Of Advanced Medicine Holdings' Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #999999 out of 261 companies for Median PS Value. This places Singapore Institute Of Advanced Medicine Holdings in the lower half of its industry. The industry median Median PS Value is 0.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.72, based on 261 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singapore Institute Of Advanced Medicine Holdings's current Median PS Value is S$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a current Median PS Value of S$0.00. The current Median PS Value is S$0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current Median PS Value is S$0.00 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:9G2 has been successfully added to your 
